Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dextrose monohydrate + sodium lactate + potassium chloride + sodium chloride + calcium chloride is a sterile intravenous crystalloid combination solution marketed as Lactated Ringer's and Dextrose, including 5% dextrose presentations. It is a **small-molecule and inorganic salt parenteral fluid therapy** used as a source of water, electrolytes, and calories, and as an alkalinizing agent for replacement of extracellular fluid and electrolyte losses in adult and pediatric patients. The formulation supplies sodium, potassium, calcium, chloride, lactate, and dextrose; dextrose provides carbohydrate calories, while lactate is metabolized to bicarbonate and helps support acid-base balance. The product has been marketed by Hospira and ICU Medical as an intravenous injection solution for fluid and electrolyte replenishment rather than as a biologic or target-directed therapeutic.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dextrose monohydrate + sodium lactate + potassium chloride + sodium chloride + calcium chloride.